DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Clolar (Clofarabine) - Acute Myeloid Leukaemia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Acute Myeloid Leukaemia (8)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Clolar (Clofarabine) where reactions include acute myeloid leukaemia. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Clolar side effects in 62 year old male

Reported by a physician from United States on 2012-03-28

Patient: 62 year old male, weighing 71.0 kg (156.2 pounds)

Reactions: Multi-Organ Failure, Sepsis, Acute Myeloid Leukaemia, Septic Shock

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Clolar
    Dosage: 37.2 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-01-24

Clolar
    Dosage: 37.2 mg, unk
    Start date: 2012-02-17
    End date: 2012-02-17



Possible Clolar side effects in female

Reported by a physician from United States on 2012-01-10

Patient: female, weighing 73.6 kg (162.0 pounds)

Reactions: Acute Myeloid Leukaemia, Renal Failure Acute, Arrhythmia, Hypokalaemia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Clolar
    Dosage: 20 mg/m2, qd every 24 hours
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-18

Clolar
    Dosage: 20 mg/m2, qd every 24 hours
    Start date: 2011-11-07
    End date: 2011-11-11

Other drugs received by patient: Vancomycin; Voriconazole; Avelox; Armodafinil; Acyclovir; Gentamicin; Zosyn; Zithromax



Possible Clolar side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-29

Patient: female, weighing 73.6 kg (162.0 pounds)

Reactions: Acute Myeloid Leukaemia, Hypokalaemia, Renal Failure Acute, Arrhythmia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Clolar
    Dosage: 20 mg/m2, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-18

Clolar
    Dosage: 20 mg/m2, unk
    Start date: 2011-11-07
    End date: 2011-11-11

Other drugs received by patient: Zithromax; Gentamicin; Voriconazole; Acyclovir; Vancomycin; Zosyn; Avelox; Diflucan



Possible Clolar side effects in female

Reported by a physician from United States on 2011-12-22

Patient: female, weighing 73.6 kg (162.0 pounds)

Reactions: Acute Myeloid Leukaemia, Renal Failure Acute, Hypokalaemia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Clolar
    Dosage: 20 mg/m2, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-18

Clolar
    Dosage: 20 mg/m2, unk
    Start date: 2011-11-07
    End date: 2011-11-11

Other drugs received by patient: Voriconazole; Zosyn; Vancomycin Hychloride; Zithromax; Avelox; Gentamicin; Zyvox



Possible Clolar side effects in female

Reported by a physician from United States on 2011-12-09

Patient: female, weighing 73.6 kg (162.0 pounds)

Reactions: Acute Myeloid Leukaemia, Hypokalaemia, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Clolar
    Dosage: 20 mg/m2, unk
    Start date: 2011-11-07
    End date: 2011-11-11

Clolar
    Dosage: 20 mg/m2, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-18

Other drugs received by patient: Zyvox; Zithromax; Vancomycin; Zosyn; Voriconazole; Gentamicin; Avelox



Possible Clolar side effects in 36 year old female

Reported by a physician from Mexico on 2011-10-25

Patient: 36 year old female, weighing 78.0 kg (171.6 pounds)

Reactions: Acute Myeloid Leukaemia, Bone Marrow Failure

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Cytarabine
    Dosage: 1 g/m2, qdx5
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-04-12
    End date: 2011-04-16

Clolar
    Dosage: 40 mg/m2, qdx5
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-04-12
    End date: 2011-05-01

Other drugs received by patient: Neupogen



Possible Clolar side effects in 36 year old female

Reported by a physician from Mexico on 2011-10-20

Patient: 36 year old female, weighing 78.0 kg (171.6 pounds)

Reactions: Acute Myeloid Leukaemia, Bone Marrow Failure

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Cytarabine
    Dosage: 1 g/m2, qdx5
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-04-12
    End date: 2011-04-16

Clolar
    Dosage: 40 mg/m2, qdx5
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-04-12
    End date: 2011-05-01

Other drugs received by patient: Neupogen



Possible Clolar side effects in 36 year old female

Reported by a physician from Mexico on 2011-10-17

Patient: 36 year old female, weighing 78.0 kg (171.6 pounds)

Reactions: Acute Myeloid Leukaemia, Bone Marrow Failure

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Cytarabine
    Dosage: 1 g/m2, qdx5
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-04-12
    End date: 2011-04-16

Clolar
    Dosage: 40 mg/m2, qdx5
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-05-01
    End date: 2011-05-01

Other drugs received by patient: Neupogen

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017